| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Dec 19, 2024 | Dec 19, 2024 | Budd Haeberlein Samantha L. Dir | Buy | $1.71 | $20,520 | +50.00% |
| Dec 19, 2024 | Dec 19, 2024 | Magovcevic-Liebisch Ivana Pres CEO | Buy | $1.68 | $8,400 | +2.20% |
| Dec 18, 2024 | Dec 18, 2024 | Magovcevic-Liebisch Ivana Pres CEO | Buy | $1.67 | $8,350 | +2.25% |
| Dec 05, 2024 | Dec 05, 2024 | Magovcevic-Liebisch Ivana Pres CEO | Buy | $2.34 | $11,700 | +2.30% |
| Nov 20, 2023 | Nov 20, 2023 | Magovcevic-Liebisch Ivana Pres CEO | Buy | $3.75 | $15,000 | +1.89% |
| Nov 18, 2022 | Nov 23, 2022 | Papapetropoulos Spyros Chief Medical Officer | Sell | $14 | $4,200 | -6.98% |
| May 16, 2022 | May 18, 2022 | Thorp Clay Dir | Buy | $2.85 | $104,411 | +2.30% |
| May 05, 2022 | May 06, 2022 | Thackaberry Evan SVP Head of Early Development | Buy | $4 | $6,000 | +50.00% |
| May 03, 2022 | May 04, 2022 | Verni Christopher GC | Buy | $3.77 | $15,074 | +50.00% |
| May 02, 2022 | May 04, 2022 | Magovcevic-Liebisch Ivana Pres CEO | Buy | $3.68 | $18,379 | +2.40% |
| May 03, 2022 | May 04, 2022 | Ziolkowski Jennifer Lynn CFO | Buy | $3.77 | $15,098 | +50.00% |
| May 03, 2022 | May 04, 2022 | Papapetropoulos Spyros Chief Medical Officer | Buy | $3.4 | $13,591 | +50.00% |
| Mar 28, 2022 | Mar 28, 2022 | Thorp Clay Dir | Buy | $7.2 | $21,604 | +0.20% |
| Jan 11, 2022 | Jan 12, 2022 | Thorp Clay Dir | Buy | $14 | $4M | +14.85% |
| Jan 11, 2022 | Jan 12, 2022 | Vida Ventures Gp Iii, L.L.C. 10% | Buy | $14 | $23M | +25.03% |
| Jan 11, 2022 | Jan 12, 2022 | Atlas Venture Fund Xii, L.P. 10% | Buy | $14 | $7M | +8.40% |
| Jan 11, 2022 | Jan 12, 2022 | Booth Bruce Dir | Buy | $14 | $7M | +8.40% |
| Jan 11, 2022 | Jan 12, 2022 | Vitorovic Stefan Dir | Buy | $14 | $23M | +25.03% |
| Jan 11, 2022 | Jan 12, 2022 | Northpond Ventures Gp, LLC 10% | Buy | $14 | $5M | +7.77% |